Press Releases

12-11-2019

Eckert & Ziegler: Strong nine-month figures. Annual forecast confirmed. Pooling of medical segments in 2020.

30-08-2019

Eckert & Ziegler to supply radioisotopes to Alpha Tau

27-08-2019

Eckert & Ziegler: additional production capacities for Gallium-68-Generators released by supervisory authorities

13-08-2019

Eckert & Ziegler: Strong Growth in Sales and Income

01-08-2019

Eckert & Ziegler forms joint venture for tumor irradiation devices in China

29-07-2019

Eckert & Ziegler: EZAG to set up radiopharmaceutical production facility in China

26-07-2019

Eckert & Ziegler: EMA Grants Drug Designation to EZAG Affiliate

22-07-2019, 19:19 CEST (Ad hoc press release)

Eckert & Ziegler Increases Profit Forecast to 4 Euro per Share

06-06-2019

Eckert & Ziegler will be admitted to SDax

29-05-2019

Eckert & Ziegler: Shareholders approve dividend of 1.20 EUR. Frank Perschmann joins Supervisory Board

14-05-2019

Eckert & Ziegler will be admitted to the MSCI Germany Small Cap Index

07-05-2019

Eckert & Ziegler off to a strong start in 2019

11-04-2019

Merger between Eckert & Ziegler BEBIG SA (BEBIG) and Eckert & Ziegler Strahlen – und Medizintechnik AG (EZAG) - Completion of the sale of the full EZAG Exchange Shares resulting from the partial rights further to the merger

05-04-2019

Eckert & Ziegler delivers a record result

02-04-2019

Eckert & Ziegler will be admitted to the MSCI Germany Small Cap Index

26-03-2019, 18:58 CET (Ad hoc press release)

Eckert & Ziegler Increases Dividend

20-03-2019

Eckert & Ziegler Awarded for Excellent Training Quality

18-02-2019

Eckert & Ziegler: Merger with Belgian Eckert & Ziegler BEBIG SA Successfully Completed

21-01-2019, 12:44 CET (Ad hoc press release)

Eckert & Ziegler 2018: Revenue and earnings higher than expected

Karolin Riehle
+49 30 94 10 84-138
karolin.riehle@dont-want-spam.ezag.de